Publikationen, an denen er mitarbeitet Ginés Luengo Gil (2)

2023

  1. Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

    Frontiers in Molecular Biosciences, Vol. 10

2021

  1. Anti-tumor functions of prelatent antithrombin on glioblastoma multiforme cells

    Biomedicines, Vol. 9, Núm. 5